Approval · Notice of Compliance 21111 · 2018
FLAGYL: Notice of Compliance 21111
Issued July 19, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21111
- Date
- July 19, 2018
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To include amr class labelling request and remove referencews to the 500 mg capsules
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAGYL | Not yet assigned | — |
Medicinal ingredients
- METRONIDAZOLE 10 PER
- METRONIDAZOLE 500 MG per CAP